Think tank calls for FDA to hike foreign inspections . . .

ITIF: China Poses Competitive Threat To U.S. Pharma, Could Lower Prices

By Beth Wang / August 14, 2019 at 3:46 PM
Generic drug makers in the United States could experience an uptick in competition from China in the next 10 years, according to a non-profit think tank that focuses on public policy and innovation. Though that might not be good news for U.S. drug companies, especially if they continue to face potential intellectual property (IP) theft and hacking by the Chinese, the think tank argues that if China can improve its regulatory and approval system and cut back on “unfair, mercantilist”...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.